Literature DB >> 33006799

Predicting adverse drug reactions of two-drug combinations using structural and transcriptomic drug representations to train an artificial neural network.

Susmitha Shankar1, Ishita Bhandari2, David T Okou3, Gowri Srinivasa2, Prashanth Athri1.   

Abstract

Adverse drug reactions (ADRs) are pharmacological events triggered by drug interactions with various sources of origin including drug-drug interactions. While there are many computational studies that explore models to predict ADRs originating from single drugs, only a few of them explore models that predict ADRs from drug combinations. Further, as far as we know, none of them have developed models using transcriptomic data, specifically the LINCS L1000 drug-induced gene expression data to predict ADRs for drug combinations. In this study, we use the TWOSIDES database as a source of ADRs originating from two-drug combinations. 34,549 common drug pairs between these two databases were used to train an artificial neural network (ANN), to predict 243 ADRs that were induced by at least 10% of the drug pairs. Our model predicts the occurrence of these ADRs with an average accuracy of 82% across a multifold cross-validation.
© 2020 John Wiley & Sons A/S.

Entities:  

Keywords:  ADR; LINCS L1000; TWOSIDES dataset; adverse drug reaction; artificial intelligence; artificial neural network; drug-drug interaction; transcriptomic data

Year:  2020        PMID: 33006799     DOI: 10.1111/cbdd.13802

Source DB:  PubMed          Journal:  Chem Biol Drug Des        ISSN: 1747-0277            Impact factor:   2.817


  2 in total

Review 1.  On the road to explainable AI in drug-drug interactions prediction: A systematic review.

Authors:  Thanh Hoa Vo; Ngan Thi Kim Nguyen; Quang Hien Kha; Nguyen Quoc Khanh Le
Journal:  Comput Struct Biotechnol J       Date:  2022-04-19       Impact factor: 6.155

2.  DeSIDE-DDI: interpretable prediction of drug-drug interactions using drug-induced gene expressions.

Authors:  Eunyoung Kim; Hojung Nam
Journal:  J Cheminform       Date:  2022-03-04       Impact factor: 5.514

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.